• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALA 4.55% 11.5¢

AROVELLA THERAPEUTICS LIMITED

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ALA 23/05/24 0 212
23/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  212 
ALA 23/05/24 3 2.0K
23/05/24 Last post  standalone Comments Created with Sketch.  3  Views Created with Sketch.  2.0K 
ALA 23/05/24 1 496
TRENDING NEWS

Australian-listed companies chase the rainbow of the renewable energy market

NEWS
24 May 2024
23/05/24 Last post  ASX News Comments Created with Sketch.  1  Views Created with Sketch.  496 
ALA
Arovella Potential Future State Deals
16/05/24 0 498
16/05/24 Last post  Kelvin8r Comments Created with Sketch.  0  Views Created with Sketch.  498 
ALA
Arovella
15/05/24 6 2.9K
15/05/24 Last post  nchiwla Comments Created with Sketch.  6  Views Created with Sketch.  2.9K 
ALA 01/05/24 0 566
01/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  566 
ALA
Breakout Looming?
4 5 6
29/04/24 351 156K
29/04/24 Last post  portsea7 Comments Created with Sketch.  351  Views Created with Sketch.  156K 
ALA 26/04/24 3 1.6K
26/04/24 Last post  abitlikeme Comments Created with Sketch.  3  Views Created with Sketch.  1.6K 

See All Discussions arrow Created with Sketch.

Timeline

Results of Meeting
23 May 15:51
 
EGM Company Presentation
23 May 10:54
 
Updated Share Trading Policy
01 May 11:38
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 09:51
 
Proposed issue of securities - ALA
23 Apr 13:41
 
Notice of Extraordinary General Meeting/Proxy Form
23 Apr 13:26
 
View More arrow Created with Sketch.
(20min delay)
Last
11.5¢
Change
0.005(4.55%)
Mkt cap ! $120.7M
Open High Low Value Volume
11.5¢ 12.0¢ 11.3¢ $125.0K 1.087M

Buyers (Bids)

No. Vol. Price($)
2 285250 11.5¢
 

Sellers (Offers)

Price($) Vol. No.
12.0¢ 326574 6
View Market Depth
Last trade - 13.41pm 24/05/2024 (20 minute delay) ?
Last
12.0¢
  Change
0.005 ( 6.67 %)
Open High Low Volume
11.5¢ 12.0¢ 11.5¢ 340766
Last updated 14.31pm 24/05/2024 ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.